期刊文献+

不同筛查工具对肺癌术后辅助化疗患者营养筛查的比较 被引量:9

下载PDF
导出
摘要 目的比较不同营养筛查工具间评估肺癌术后辅助化疗患者的营养风险的差异。方法前瞻性评估63例拟行肺癌术后辅助化疗患者,利用NRS2002及SGA作营养筛查,测定体质指数判断营养状况,分析各营养筛查方法的关系。结果63例患者均完成NRS2002和SGA。用BMI中国标准判定营养不足、超重和肥胖发生率分别为17.5%、28.6%和3.2%。NRS2002筛查显示营养风险发生率为55.6%,SGA筛查显示营养不足发生率为53.9%;两种方法在营养不足筛查结果间差异无显著性(P=0.723)。结论NRS2002和SGA均适用于肺癌术后辅助化疗患者营养风险筛查。
作者 胡昆卓 乔坤
出处 《广东医学》 CAS CSCD 北大核心 2009年第8期1140-1141,共2页 Guangdong Medical Journal
  • 相关文献

参考文献6

  • 1EDINGTON J, BOORMAN J, DURRANT E R, et al. Prevalence of malnutrition on admission to four hospitals in England[J]. Clin Nutr, 2000, 19(3) : 191 -195.
  • 2MCWHIRTER J P, PENNINGTON C R. Incidence and recognition of malnutrition in hospital[J]. Br Med J, 1994, 308:945 - 948.
  • 3夏照华,胡昆卓,王正,杨林,欧竹君,林少霖.恶性肿瘤患者体质量减轻的治疗进展[J].临床荟萃,2008,23(1):74-76. 被引量:2
  • 4夏照华,胡昆卓,王正,杨林,林少霖,欧竹君.住院患者能量消耗和营养支持的研究进展[J].实用医学杂志,2008,24(16):2906-2907. 被引量:7
  • 5KONDRUP J, ALLISON S P, ELIA M, et al. ESPEN Guidelines for Nutrition Screening 2002 [J].Clin Nutr, 2003, 22 ( 3 ) : 415 -421.
  • 6KONDRUP J, RASMUSSEN H H, HAMBERG O, et al. Nutritional Risk Screening ( NRS 2002) : a new method based on an a- nalysis of controlled clinical trials[ J]. Clin Nutr, 2003, 22( 3 ) : 321 - 336.

二级参考文献30

  • 1Malik NM, Liu dexamethasone, YL, Cole N, et al. Differential effects of ondansetron and a tachykinin NK1receptor antagonist ( GR205171 ) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats[J]. Eur J Pharmacol,2007,555(2-3) :164-173.
  • 2Khan ZH ,Simpson EJ, Cole AT, et al. Oesophageal cancer and cachexia:the effect of short-term treatment with thalidomide on weight loss and lean body mass[J]. Aliment Pharmacol Ther, 2003,17(5) :677-682.
  • 3Bruera E, Strasser F, Palmer JL, et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia:a double-blind placebo-controlled study [J]. J Clin Oncol,2003,21(1) :129-134.
  • 4Fearon KC, von Meyenfeldt MF, Moses AG, et al. Effect of protein and energy dense N-3 fatty acid enriched oral supplement of loss of weight and lean tissue in cancer caehexia: a randomized double blind trial[J]. Gut, 2003,52 (10) : 1391- 1392.
  • 5Persson C,Glimelius B, Ronnelid J, et al. Impact of fish oil and melatonin on caehexia in patients with advanced gastrointestinal cancer:a randomized pilot study[J]. Nutrition, 2005,21 (2) : 170-178.
  • 6Palombine J. Cancer-related weight loss[J]. Clin J Oncol Nurs, 2006,10(6) :831-832.
  • 7Skipworth RJ,Stewart GD, Dejong CH, et al. Pathophysiology of cancer eaehexia: Much more than host-tumor interaction[J] ? Clin Nutr,2007,26(4):433-437.
  • 8Tomiska M, Tomiskova M, Salajka F, et al. Palliative treatment of cancer anorexia with oral suspension of megestrol acetate [J]. Neoplasma, 2003,50(3) :227-233.
  • 9Diament MJ,Peluffo GD, Stillitani I, et al. Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocareinoma by medroxyprogesterone acetate and indomethaein[J]. Cancer Invest,2006,24(2) : 126-131.
  • 10Jatoi A, Windschitl HE, Loprinzi CL, et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia:a North Central Cancer Treatment Group Study[J]. J Clin Oncol, 2002,20(2) : 567-573.

共引文献6

同被引文献93

引证文献9

二级引证文献108

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部